home / stock / lci / lci news


LCI News and Press, Lannett Co Inc From 05/05/20

Stock Information

Company Name: Lannett Co Inc
Stock Symbol: LCI
Market: NYSE

Menu

LCI LCI Quote LCI Short LCI News LCI Articles LCI Message Board
Get LCI Alerts

News, Short Squeeze, Breakout and More Instantly...

LCI - Lannett Q3 2020 Earnings Preview

Lannett (NYSE: LCI ) is scheduled to announce Q3 earnings results on Wednesday, May 6th, after market close. The consensus EPS Estimate is $0.28 (-58.8% Y/Y) and the consensus Revenue Estimate is $134.55M (-22.1% Y/Y). Over the last 2 years, LCI has beaten EPS estimates 75% of the ti...

LCI - Lannett To Report Fiscal 2020 Third-Quarter Financial Results, Host Conference Call On Wednesday, May 6

PHILADELPHIA , April 29, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2020 third quarter on Wednesday, May 6, 2020 , after the market closes. Lannett management will host a conference call that same ...

LCI - Most Heavily Shorted Stocks - April 2020

It's been an exciting time to be an active trader in the market. The emergence of the coronavirus pandemic has sparked a historic wave of volatility which in part reflects the challenge for investors to reconcile the near-term transitory disruptions against potential longer-lasting consequence...

LCI - Lannett To Meet With FDA Regarding The Clinical Advancement Of Biosimilar Insulin Glargine On June 9

PHILADELPHIA , April 8, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it is set to meet with the U.S. Food and Drug Administration (FDA) on June 9, 2020 to plan next steps for the clinical advancement of its biosimilar insulin glargine partnered produc...

LCI - Lannett Begins Marketing Generic Adderall® XR

PHILADELPHIA , March 31, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced marketing a generic version of Adderall XR ® , an extended-release mixed salt of a single entity Amphetamine capsule product (Dextroamphetamine Saccharate, Amphe...

LCI - Mylan waives exclusive U.S. rights to generic Kaletra; shares down 4%

Aimed at increasing supply during the COVID-19 pandemic, Mylan N.V. ( MYL -3.9% ) has waived its exclusive U.S. distribution rights for a generic version of AbbVie's ( ABBV +2.8% ) HIV antiviral combo pill Kaletra (lopinavir/ritonavir). More news on: Mylan N.V., AbbVie Inc., Lannett ...

LCI - Recreation stocks slide again

Recreation stocks are trading as if no is planning to go outside this spring. More news on: Thor Industries, Inc., Winnebago Industries, Inc., Polaris Inc., Consumer stocks news, Stocks on the move Read more ...

LCI - Lannett To Present At The 32nd annual Roth Conference On March 16

PHILADELPHIA , March 9, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the 32nd Annual ROTH Conference on March 16, 2020 at 2:30 p.m. PT at The Ritz Carlton, in Laguna Niguel, California.  A webcast of t...

LCI - FDA implements new rule aimed at boosting competition in insulin

Effective March 20, the FDA will institute a new rule that marketing applications for biologics, including insulins, will be regarded as licenses under the Public Health Service Act, enabling the filing of applications for biosimilars. The agency says the rule should enhance the transition...

LCI - Here's What to Like About Lannett's Q2 Earnings Results

Lannett  (NYSE: LCI)  has gone through some rough patches in recent years. The stock was sizzling hot in 2019, skyrocketing 78%, but that sizzle has fizzled out so far in 2020. Investors hoping for a spark from Lannett's second-quarter results had some things to like. The generic-dr...

Previous 10 Next 10